Veloxis Pharmaceuticals Announces Financial Calendar for 2015


Company Announcement no. 27/2014

 

To: NASDAQ OMX Copenhagen A/S                                Hørsholm, Denmark, 16 December 2014

 

Veloxis Pharmaceuticals Announces Financial Calendar for 2015

 

Veloxis Pharmaceuticals A/S (OMX: VELO) today announced financial calendar for 2015.

 

4. March, 2015:               Release of Annual Report 2014.

26 March, 2015:              Annual General Meeting.

20 May, 2015:                Interim Report for the 1st Quarter for the period 1 January to 31 March, 2015.

26 August, 2015:            Interim Report for the 2nd Quarter – for the period 1 January to 30 June, 2015.

11 November, 2015:       Interim Report for the 3rd Quarter – for the period 1 January to 30 September, 2015.

  

For more information, please contact:

 

Veloxis Pharmaceuticals A/S

Bill Polvino                                Johnny Stilou

President & CEO                        EVP, Chief Financial Officer

Mobile: +1 917 647 9107           Mobile: +45 21 227 227

Email: wjp@veloxis.com             Email: jst@veloxis.com

  

About Veloxis Pharmaceuticals

Based in Hørsholm, Denmark, with an office in New Jersey, Veloxis Pharmaceuticals A/S, or Veloxis, is a specialty pharmaceutical company. Veloxis’ unique, patented delivery technology, MeltDose®, is designed to enhance the absorption and bioavailability of select orally administered drugs. Veloxis is listed on the NASDAQ OMX Copenhagen under the trading symbol OMX: VELO.

For further information, please visit www.veloxis.com.

 


Attachments

161214 Veloxis Announces Financial calendar 2015.pdf